Literature DB >> 9579178

Spontaneous rupture of renal tumours: the role of imaging in diagnosis and management.

K H Yip1, W C Peh, P C Tam.   

Abstract

This study aimed to evaluate whether patients presenting with spontaneous haemorrhage from renal tumours could be accurately diagnosed and initially managed conservatively, and evaluate the role of imaging in guiding the timing and type of subsequent operation. The clinical features, imaging findings and management of seven patients presenting with spontaneous rupture of renal tumour over a 5-year period were reviewed. The information from various imaging studies was evaluated in relation to the subsequent course of intervention. The tumours consisted of six angiomyolipomas and one renal cell carcinoma. In all cases, imaging studies were diagnostic, with computed tomography being the most useful single modality. Emergency surgery was required in one patient for evacuation of suspected infected haematoma and wedge excision of angiomyolipoma. Three elective nephrectomies were performed, while three other patients with ruptured angiomyolipoma were treated conservatively and remained well, without any intervention. In conclusion, patients presenting with spontaneous rupture of renal tumour can be managed conservatively initially. Imaging facilitates accurate pre-operative diagnosis, which was angiomyolipoma in all but one patient in this series. The subsequent intervention can be tailored according to the lesion type and the anticipated risk of re-haemorrhage.

Entities:  

Mesh:

Year:  1998        PMID: 9579178     DOI: 10.1259/bjr.71.842.9579178

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  9 in total

1.  Spontaneous life-threatening perirenal haemorrhage: an uncommon urological emergency.

Authors:  B K Somani; G Nabi; P Thorpe; S Swami
Journal:  Emerg Radiol       Date:  2005-12-07

Review 2.  Comprehensive reviews of the interfascial plane of the retroperitoneum: normal anatomy and pathologic entities.

Authors:  Su Lim Lee; Young Mi Ku; Sung Eun Rha
Journal:  Emerg Radiol       Date:  2009-04-28

3.  Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Authors:  Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2017-02

4.  Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.

Authors:  Cheng-Keng Chuang; Hsin Chia Angela Lin; Han-Yu Tasi; Kun-Han Lee; Yuting Kao; Fukai Leo Chuang; Ying-Hsu Chang; Po-Hung Lin; Chung-Yi Liu; See-Tong Pang
Journal:  Int Urol Nephrol       Date:  2017-05-25       Impact factor: 2.370

Review 5.  A right renal angiomyolipoma with IVC thrombus and pulmonary embolism.

Authors:  Y S Tan; K H Yip; P H Tan; W S Cheng
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

Review 6.  Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series.

Authors:  Thomas Ahn; Matthew J Roberts; Anojan Navaratnam; Eric Chung; Simon Wood
Journal:  Int Urol Nephrol       Date:  2017-09-04       Impact factor: 2.370

7.  Endovascular control of haemorrhagic urological emergencies: an observational study.

Authors:  Bhaskar K Somani; Ghulam Nabi; Peter Thorpe; Sam McClinton
Journal:  BMC Urol       Date:  2006-09-28       Impact factor: 2.264

8.  Wunderlich syndrome following rupture of a renal angiomyolipoma.

Authors:  Bimal Parameswaran; Mohammed Khalid; Neelam Malik
Journal:  Ann Saudi Med       Date:  2006 Jul-Aug       Impact factor: 1.526

9.  Spontaneous renal hematoma (Wünderlich syndrome) associated with severe hypertension.

Authors:  Jóse Mará Calvo-Romero; Juan Lucio Ramos-Salado
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.